Please login to the form below

Not currently logged in
Email:
Password:

Wyeth shareholders approve merger

Wyeth investors have voted to approve Pfizer's proposed $68bn takeover by an overwhelming 98 per cent, according to a preliminary tally

Wyeth investors have voted to approve Pfizer's proposed $68bn takeover by an overwhelming 98 per cent, according to a preliminary tally.

The news follows the recent announcement that the European Commission has approved the deal, subject to Pfizer's pledge to shed certain animal-health assets in Europe. The deal is still subject to clearance by anti-trust regulators in the US.

New York-based Pfizer expects the deal to close by the end of the year. 

21st July 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
McCann Health

The most globally awarded health agency network and currently Health Network agency of The Year. Comprising of two specialist agencies:...

Latest intelligence

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big...
Deal Watch January 2018
...
Emotional Intelligence and Blended Learning in Healthcare
...

Infographics